nalidixic acid has been researched along with azlocillin in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (22.22) | 18.2507 |
| 2000's | 3 (33.33) | 29.6817 |
| 2010's | 3 (33.33) | 24.3611 |
| 2020's | 1 (11.11) | 2.80 |
| Authors | Studies |
|---|---|
| Barrow, K; Kwon, DH | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Anderson, KC; Kellogg, GE; Sarkar, A | 1 |
| Andrews, JW; Conville, PS; Witebsky, FG | 1 |
| Palomino, JC; Portaels, F | 1 |
| Chang, CL; Kim, CM; Kim, HH; Lee, EY; Oh, SH; Park, TS; Son, HC | 1 |
| Brink, TL; MacLellan, KM; Passen, S; Thornton, CG | 1 |
| Dietze, R; Johnson, JL; Loureiro, RB; Maciel, EL; Palaci, M; Peres, RL | 1 |
| Joseph, A; Muzanyi, G; Nassali, J; Peace, A; Wamuntu, B | 1 |
9 other study(ies) available for nalidixic acid and azlocillin
| Article | Year |
|---|---|
Alterations in two-component regulatory systems of phoPQ and pmrAB are associated with polymyxin B resistance in clinical isolates of Pseudomonas aeruginosa.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Gene Expression Regulation, Bacterial; Humans; Microbial Sensitivity Tests; Molecular Sequence Data; Polymyxin B; Pseudomonas aeruginosa; Pseudomonas Infections; Transcription Factors | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Computational analysis of structure-based interactions and ligand properties can predict efflux effects on antibiotics.
Topics: Anti-Bacterial Agents; beta-Lactams; Computational Biology; Drug Resistance, Bacterial; Hydrophobic and Hydrophilic Interactions; Ligands; Membrane Transport Proteins; Microbial Sensitivity Tests; Models, Molecular; Protein Binding; Protein Conformation; Quantitative Structure-Activity Relationship; Regression Analysis; Thermodynamics | 2012 |
Effect of PANTA on growth of Mycobacterium kansasii in BACTEC 12B medium.
Topics: Amphotericin B; Azlocillin; Bacteriological Techniques; Culture Media; Drug Resistance, Microbial; Drug Therapy, Combination; Evaluation Studies as Topic; Humans; Mycobacterium Infections, Nontuberculous; Nalidixic Acid; Nontuberculous Mycobacteria; Polymyxin B; Trimethoprim | 1995 |
Effects of decontamination methods and culture conditions on viability of Mycobacterium ulcerans in the BACTEC system.
Topics: Amphotericin B; Anti-Bacterial Agents; Azlocillin; Culture Media; Egg Yolk; Hydrochloric Acid; Mycobacterium ulcerans; Nalidixic Acid; Oxalates; Oxalic Acid; Polyethylene Glycols; Polymyxin B; Sodium Hydroxide; Trimethoprim | 1998 |
Reduction of contamination of mycobacterial growth indicator tubes with a modified antimicrobial combination.
Topics: Amphotericin B; Anti-Bacterial Agents; Azlocillin; Drug Interactions; Humans; Mycobacterium; Nalidixic Acid; Polymyxin B; Trimethoprim; Vancomycin | 2002 |
Characterization of the susceptibility of mycobacteria in BACTEC 12B media containing PANTA that had been supplemented with ceftazidime, and characterization of the individual components of PANTA in the presence of C18-carboxypropylbetaine.
Topics: Anti-Bacterial Agents; Azlocillin; Bacteriological Techniques; Betaine; Ceftazidime; Culture Media; Mycobacterium; Nalidixic Acid; Polymyxin B; Trimethoprim | 2004 |
Reduction of contamination of mycobacterial growth indicator tubes using increased PANTA concentration.
Topics: Amphotericin B; Anti-Bacterial Agents; Azlocillin; Bacteriological Techniques; Culture Media; Disposable Equipment; Dose-Response Relationship, Drug; Equipment Contamination; Humans; Mycobacterium tuberculosis; Nalidixic Acid; Polymyxin B; Predictive Value of Tests; Prospective Studies; Sputum; Trimethoprim; Tuberculosis, Pulmonary | 2011 |
The threat of persistent bacteria and fungi contamination in tuberculosis sputum cultures.
Topics: Amphotericin B; Anti-Bacterial Agents; Azlocillin; Bacteria; Bacteriological Techniques; Fungi; Humans; Longitudinal Studies; Mycobacterium tuberculosis; Nalidixic Acid; Polymyxin B; Sputum; Trimethoprim; Tuberculosis | 2021 |